Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade.
By S. Dovedi, Amy L. Adlard, G. Lipowska-Bhalla, Conor McKenna, Sherrie Jones, E. Cheadle, I. Stratford, Edmund Poon, Michelle Morrow, R. Stewart and 4 more. Cancer Research, 2014
1,169 citations recorded by the source corpus.
Subfields: Immunology, Oncology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/9b45d18bce9ad95ba2f6a0ff32d464bc962712b9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Anti-Tumor Immune Responses via Cross-Presentation of Tumor Antigen (2014, background): “Recently, there have been reports that radiation alone can result in increased expression of PD-1 ligands on the surface of tumor cells (37, 38), including melanoma and breast cancer model cell lines.”